Skip to main content

Advertisement

Log in

Are fatty acids associated with disease activity and biomarkers in patients with psoriatic arthritis? Data from a multicenter clinical trial

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The pathogenesis of psoriatic arthritis (PsA) involves inflammation and bone and soft tissue turnover. Dietary fatty acids have previously been associated with pro-inflammatory effects induced by saturated fatty acids (SFA) and anti-inflammatory effects achieved by at least some polyunsaturated fatty acids (PUFA). The aim of the study was to investigate the correlations between the content of fatty acids in granulocytes and clinical and biochemical markers of PsA. A total of 140 patients with PsA were included. Skin and joint disease activity were assessed. Fatty acid composition in granulocytes was determined by gas chromatography. Competitive enzyme-linked immunosorbent assays were used to assess bone and soft tissue turnover. The content of SFA, n-6 PUFA or n-3 PUFA in granulocytes was not associated with disease activity. Marine n-3 PUFA was significantly positively correlated with collagen degradation. In contrast, n-6 PUFA was significantly positively correlated with collagen formation and negatively correlated with collagen degradation. However, the correlations were all weak. No association was found between the content of fatty acids in granulocytes and disease activity in this population of patients with PsA. The correlation between fatty acids and biomarkers of bone and soft tissue turnover needs further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Veale DJ, Fearon U (2018) The pathogenesis of psoriatic arthritis. Lancet 391:2273–2284. https://doi.org/10.1016/S0140-6736(18)30830-4

    Article  CAS  PubMed  Google Scholar 

  2. Schett G, Coates LC, Ash ZR, Finzel S, Conaghan PG (2011) Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future. Arthritis Res Ther 13:S4

    Article  Google Scholar 

  3. Bartosińska J, Michalak-Stoma A, Juszkiewicz-Borowiec M, Kowal M, Chodorowska G (2015) The assessment of selected bone and cartilage biomarkers in psoriatic patients from Poland. Mediat Inflamm. https://doi.org/10.1155/2015/194535

    Article  Google Scholar 

  4. Jadon DR, Nightingale AL, McHugh NJ, Lindsay MA, Korendowych E, Sengupta R (2015) Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy. J Rheumatol 42:21–30. https://doi.org/10.3899/jrheum.140223

    Article  CAS  PubMed  Google Scholar 

  5. Katsimbri P, Korakas E, Kountouri A, Ikonomidis I, Tsougos E, Vlachos D et al (2021) The effect of antioxidant and anti-inflammatory capacity of diet on psoriasis and psoriatic arthritis phenotype: nutrition as therapeutic tool? Antioxidants (Basel, Switzerland). https://doi.org/10.3390/antiox10020157

    Article  Google Scholar 

  6. Gioxari A, Kaliora AC, Marantidou F, Panagiotakos DP (2018) Intake of ω-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a systematic review and meta-analysis. Nutrition 45:114-124.e4. https://doi.org/10.1016/j.nut.2017.06.023

    Article  CAS  PubMed  Google Scholar 

  7. Pc C (2006) N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83:1505S-S1511

    Article  Google Scholar 

  8. Calder PC (2015) Functional roles of fatty acids and their effects on human health. JPEN 39:18S-32S. https://doi.org/10.1177/0148607115595980

    Article  Google Scholar 

  9. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB (2003) Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 108:155–160. https://doi.org/10.1161/01.CIR.0000079224.46084.C2

    Article  CAS  PubMed  Google Scholar 

  10. Nyirenda MH, Sanvito L, Darlington PJ, O’Brien K, Zhang G-X, Constantinescu CS et al (2011) TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function. J Immunol 187:2278–2290. https://doi.org/10.4049/jimmunol.1003715

    Article  CAS  PubMed  Google Scholar 

  11. Nicholas DA, Zhang K, Hung C, Glasgow S, Aruni AW, Unternaehrer J et al (2017) Palmitic acid is a toll-like receptor 4 ligand that induces human dendritic cell secretion of IL-1β. PLoS ONE 12:e0176793. https://doi.org/10.1371/journal.pone.0176793

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kim HH, Shin CM, Park CH, Kim KH, Cho KH, Eun HC et al (2005) Eicosapentaenoic acid inhibits UV-induced MMP-1 expression in human dermal fibroblasts. J Lipid Res. https://doi.org/10.1194/jlr.M500105-JLR200

    Article  PubMed  Google Scholar 

  13. Myśliwiec H, Baran A, Harasim-Symbor E, Myśliwiec P, Milewska AJ, Chabowski A et al (2017) Serum fatty acid profile in psoriasis and its comorbidity. Arch Dermatol Res. https://doi.org/10.1007/s00403-017-1748-x

    Article  PubMed  PubMed Central  Google Scholar 

  14. Coras R, Kavanaugh A, Boyd T, Huynh Q, Pedersen B, Armando AM et al (2019) Pro- and anti-inflammatory eicosanoids in psoriatic arthritis. Metabolomics 15:65. https://doi.org/10.1007/s11306-019-1527-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lassus A, Dahlgren AL, Halpern MJ, Santalahti J, Happonen HP (1990) Effects of dietary supplementation with polyunsaturated ethyl ester lipids (Angiosan) in patients with psoriasis and psoriatic arthritis. J Int Med Res 18: 68–73. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med3&NEWS=N&AN=2139859

  16. Kristensen S, Schmidt EB, Schlemmer A, Rasmussen C, Johansen MB, Christensen JH (2018) Beneficial effect of n-3 polyunsaturated fatty acids on inflammation and analgesic use in psoriatic arthritis: a randomized, double blind, placebo-controlled trial. Scand J Rheumatol. https://doi.org/10.1080/03009742.2017.1287304

    Article  PubMed  Google Scholar 

  17. Veale DJ, Torley HI, Richards IM, O’Dowd A, Fttzsimons C, Belch JJF et al (1994) A double-blind placebo controlled trial of efamol marine on skin and joint symptoms of psoriatic arthritis. Rheumatology 33:954–958. https://doi.org/10.1093/rheumatology/33.10.954

    Article  CAS  Google Scholar 

  18. Madland TM, Björkkjaer T, Brunborg LA, Fröyland L, Berstad A, Brun JG (2006). Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil. A pilot study with double blind comparison to soy oil. J Rheumatol 33: 307–310. http://www.ncbi.nlm.nih.gov/pubmed/16465662

  19. Joensen AM, Overvad K, Dethlefsen C, Johnsen SP, Tjønneland A, Rasmussen LH et al (2011) Marine n-3 polyunsaturated fatty acids in adipose tissue and the risk of acute coronary syndrome. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.110.987057

    Article  PubMed  Google Scholar 

  20. Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C (2012) Health implications of high dietary omega-6 polyunsaturated fatty acids. J Nutr Metab. https://doi.org/10.1155/2012/539426

    Article  PubMed  PubMed Central  Google Scholar 

  21. Barrea L, Macchia PE, Tarantino G, Somma C, Pane E, Balato N et al (2015) Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire. J Transl Med. https://doi.org/10.1186/s12967-015-0658-y

    Article  PubMed  PubMed Central  Google Scholar 

  22. Mysliwiec H, Harasim-Symbor E, Baran A, Szterling-Jaworowska M, Milewska AJ, Chabowski A et al (2019) Abnormal serum fatty acid profile in psoriatic arthritis. Arch Med Sci. https://doi.org/10.5114/aoms.2019.89451

    Article  PubMed  PubMed Central  Google Scholar 

  23. Schmidt EB, Varming K, Møller JM, Bülow Pedersen I, Madsen P, Dyerberg J (1996) No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans. Scand J Clin Lab Invest. https://doi.org/10.1080/00365519609088592

    Article  PubMed  Google Scholar 

  24. Gudmann NS, Siebuhr AS, Christensen AF, Ejstrup L, Sørensen GL, Loft AG et al (2017) Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacity. Clin Exp Rheumatol 35:653–659

    PubMed  Google Scholar 

  25. Thudium CS, Nielsen SH, Sardar S, Mobasheri A, van Spil WE, Lories R et al (2020) Bone phenotypes in rheumatology—there is more to bone than just bone. BMC Musculoskelet Disord 21:789. https://doi.org/10.1186/s12891-020-03804-2

    Article  PubMed  PubMed Central  Google Scholar 

  26. Coras R, Kavanaugh A, Boyd T, Huynh Q, Pedersen B, Armando AM, et al (2019) Pro- and anti-inflammatory eicosanoids in psoriatic arthritis. Metabolomics 15:65. https://doi.org/10.1007/s11306-019-1527-0

Download references

Funding

This work was supported by the Danish Research Foundation “Den Danske Forskningsfond”, the Innovation Fund Denmark (Innovationsfonden), the Danish Rheumatism Association and the Danish Psoriasis Foundation.

Author information

Authors and Affiliations

Authors

Contributions

Concept and design: All authors. Conduction of the trial: SK. Fatty acid analysis SK and EBS. Biomarker analysis: SHN and ACBJ. Drafting of the manuscript: SK. Statistical analysis: SK and SHN. Critical revision of the manuscript for important intellectual content: All authors. Supervision: EBS, JHC, MAK, ACBJ.

Corresponding author

Correspondence to Salome Kristensen.

Ethics declarations

SHN, ACBJ and MAK are full-time employee at Nordic Bioscience A/S. Nordic Bioscience is a privately owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. MAK holds stocks in Nordic Bioscience A/S. None of the authors received fees, bonuses or other benefits for the work described in the manuscript.

Ethical approval

All participants gave their oral and written informed consent and the regional ethics committee of North Denmark approved the study (reference number N20120076). The study was approved by the Danish Data Protection Agency (2008-58-0028) and registered at ClinicalTrials.gov (NCT01818804). The study was conducted in accordance with the Declaration of Helsinki.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kristensen, S., Nielsen, S.H., Schmidt, E.B. et al. Are fatty acids associated with disease activity and biomarkers in patients with psoriatic arthritis? Data from a multicenter clinical trial. Rheumatol Int 42, 1009–1014 (2022). https://doi.org/10.1007/s00296-021-04953-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-04953-w

Keywords

Navigation